Planned Sale of 303,739 PACB Shares Filed

An investor in PACB filed a Rule 144 notice covering the planned sale of 303,739 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on 02/17/2026 on the NASDAQ market.

Accepted by SEC EDGAR 02/17/2026 - 06:27 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

An investor in PACB filed a Rule 144 notice covering the planned sale of 303,739 shares of common stock through Morgan Stanley Smith Barney LLC Executive Financial Services on 02/17/2026 on the NASDAQ market.

The filing lists an aggregate market value of 478,692.66 for the shares to be sold and notes that 301,907,431 shares of this class were outstanding. The seller acquired these shares as restricted stock from the issuer on 02/15/2026, with no special payment terms disclosed.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many PACB shares are included in this Rule 144 sale notice?

The notice covers the planned sale of 303,739 shares of PACB common stock. These shares were acquired as restricted stock from the issuer and are now being registered for potential resale under Rule 144 on the NASDAQ market.

What is the aggregate market value of the PACB shares in this Rule 144 filing?

The filing states an aggregate market value of 478692.66 for the 303,739 PACB shares to be sold. This figure reflects the total market value associated with the planned Rule 144 sale through the named broker on the NASDAQ exchange.

When were the PACB shares acquired and in what form?

The PACB shares were acquired on 02/15/2026 as restricted stock directly from the issuer. The filing lists the issuer as the source and describes the nature of payment as “Not Applicable,” indicating no special non-cash payment arrangement was disclosed.

How many PACB shares were outstanding relative to this Rule 144 sale?

The filing reports 301,907,431 PACB shares outstanding for the class involved. This number provides context for the planned sale of 303,739 shares, showing the relative size of the transaction versus the total shares outstanding at the time noted.

Which broker and exchange are involved in the planned PACB share sale?

The shares are to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services, located in New York. The filing specifies that the 303,739 PACB common shares will be sold on the NASDAQ securities exchange, subject to Rule 144 conditions.

What representation does the selling PACB holder make in the Rule 144 notice?

By signing the notice, the selling holder represents that they do not know any undisclosed material adverse information about the issuer’s current or prospective operations. This statement is required in connection with the planned Rule 144 sale of the PACB shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001707477
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
SEC File Number	001-34899
Address of Issuer	1305 O'Brien Drive Menlo Park CALIFORNIA 94025
Phone	(650) 521-8000
Name of Person for Whose Account the Securities are To Be Sold	MARK VAN OENE
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	303739	478692.66	301907431	02/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2026	Restricted Stock	Issuer			303739	02/15/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Mark D. Van Oene
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)